|
1
|
Zhang YQ, Zhang JJ, Song HJ and Li DW:
Expression and prognostic influence of NF-κB and EGFR in esophageal
cancer. Genet Mol Res. 14:16819–16826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pisani P, Parkin DM, Bray F and Ferlay J:
Erratum: Estimates of the worldwide mortality from 25 cancers in
1990. Int. J. Cancer, 83, 18–29 (1999). Int J Cancer. 83:870–873.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collard JM, Otte JB, Fiasse R, Laterre PF,
De Kock M, Longueville J, Glineur D, Romagnoli R, Reynaert M and
Kestens PJ: Skeletonizing en bloc esophagectomy for cancer. Ann
Surg. 234:25–32. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blanchard P, Quero L and Hennequin C:
Prognostic and predictive factors of oesophageal carcinoma. Bull
Cancer. 96:379–389. 2009.(In French). PubMed/NCBI
|
|
8
|
Li C, Li Z, Zhu M, Zhao T, Chen L, Ji W,
Chen H and Su C: Clinicopathological and prognostic significance of
survivin over-expression in patients with esophageal squamous cell
carcinoma: A meta-analysis. PLoS One. 7:e447642012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin YC, Wu MY, Li DR, Wu XY and Zheng RM:
Prognostic and clinicopathological features of E-cadherin,
alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression
in human esophageal squamous cell carcinoma. World J Gastroenterol.
10:3235–3239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Michaylira CZ, Wong GS, Miller CG,
Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim
SB, Herlyn M, et al: Periostin, a cell adhesion molecule,
facilitates invasion in the tumor microenvironment and annotates a
novel tumor-invasive signature in esophageal cancer. Cancer Res.
70:5281–5292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen M, Cai E, Huang J, Yu P and Li K:
Prognostic value of vascular endothelial growth factor expression
in patients with esophageal cancer: A systematic review and
meta-analysis. Cancer Epidemiol Biomarkers Prev. 21:1126–1134.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Cai M, Weng Y, Zhang F, Meng D,
Song J, Zhou H and Xie Z: Circulating MACC1 as a novel diagnostic
and prognostic biomarker for nonsmall cell lung cancer. J Cancer
Res Clin Oncol. 141:1353–1361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chundong G, Uramoto H, Onitsuka T,
Shimokawa H, Iwanami T, Nakagawa M, Oyama T and Tanaka F: Molecular
diagnosis of MACC1 status in lung adenocarcinoma by
immunohistochemical analysis. Anticancer Res. 31:1141–1145.
2011.PubMed/NCBI
|
|
15
|
Shirahata A, Sakata M, Kitamura Y,
Sakuraba K, Yokomizo K, Goto T, Mizukami H, Saito M, Ishibashi K,
Kigawa G, et al: MACC 1 as a marker for peritoneal-disseminated
gastric carcinoma. Anticancer Res. 30:3441–3444. 2010.PubMed/NCBI
|
|
16
|
Burock S, Herrmann P, Wendler I,
Niederstrasser M, Wernecke KD and Stein U: Circulating metastasis
associated in colon cancer 1 transcripts in gastric cancer patient
plasma as diagnostic and prognostic biomarker. World J
Gastroenterol. 21:333–341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang T, He W, Cui F, Xia J, Zhou R, Wu Z,
Zhao Y and Shi M: MACC1 mediates acetylcholine-induced invasion and
migration by human gastric cancer cells. Oncotarget. 7:18085–18094.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun L, Duan J, Jiang Y, Wang L, Huang N,
Lin L, Liao Y and Liao W: Metastasis-associated in colon cancer-1
upregulates vascular endothelial growth factor-C/D to promote
lymphangiogenesis in human gastric cancer. Cancer Lett.
357:242–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y,
Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, et al: Overexpression of
metastasis-associated in colon cancer 1 predicts a poor outcome of
hepatitis B virus-related hepatocellular carcinoma. World J
Gastroenterol. 18:2995–3003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shirahata A, Fan W, Sakuraba K, Yokomizo
K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, et
al: MACC 1 as a marker for vascular invasive hepatocellular
carcinoma. Anticancer Res. 31:777–780. 2011.PubMed/NCBI
|
|
21
|
Yao Y, Dou C, Lu Z, Zheng X and Liu Q:
MACC1 suppresses cell apoptosis in hepatocellular carcinoma by
targeting the HGF/c-MET/AKT pathway. Cell Physiol Biochem.
35:983–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye
C, Zhu X and Li M: Overexpression of MACC1 and Its significance in
human breast cancer progression. Cell Biosci. 3:162013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shang C, Hong Y, Guo Y, Liu YH and Xue YX:
Influence of the MACC1 gene on sensitivity to chemotherapy in human
U251 glioblastoma cells. Asian Pac J Cancer Prev. 16:195–199. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Isella C, Mellano A, Galimi F, Petti C,
Capussotti L, De Simone M, Bertotti A, Medico E and Muratore A:
MACC1 mRNA levels predict cancer recurrence after resection of
colorectal cancer liver metastases. Ann Surg. 257:1089–1095. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu M, Xu Y, Mao X, Gao Y, Shao L and Yan
F: Overexpression of metastasis-associated in colon cancer-1
associated with poor prognosis in patients with esophageal cancer.
Pathol Oncol Res. 19:749–753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rikitake Y, Kawashima S, Yamashita T,
Ueyama T, Ishido S, Hotta H, Hirata Ki and Yokoyama M:
Lysophosphatidylcholine inhibits endothelial cell migration and
proliferation via inhibition of the extracellular signal-regulated
kinase pathway. Arterioscler Thromb Vasc Biol. 20:1006–1012. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang L, Wu Y, Lin L, Liu P, Huang H, Liao
W, Zheng D, Zuo Q, Sun L, Huang N, et al: Metastasis associated in
colon cancer-1 upregulation predicts a poor prognosis of gastric
cancer, and promotes tumor cell proliferation and invasion. Int J
Cancer. 133:1419–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang K, Tian F, Zhang Y, Zhu Q, Xue N,
Zhu H, Wang H and Guo X: MACC1 is involved in the regulation of
proliferation, colony formation, invasion ability, cell cycle
distribution, apoptosis and tumorigenicity by altering Akt
signaling pathway in human osteosarcoma. Tumour Biol. 35:2537–2548.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang G, Kang MX, Lu WJ, Chen Y, Zhang B
and Wu YL: MACC1: A potential molecule associated with pancreatic
cancer metastasis and chemoresistance. Oncol Lett. 4:783–791.
2012.PubMed/NCBI
|
|
30
|
Meng F, Li H, Shi H, Yang Q, Zhang F, Yang
Y, Kang L, Zhen T, Dai S, Dong Y and Han A: MACC1 downregulation
inhibits proliferation and tumourigenicity of nasopharyngeal
carcinoma cells through Akt/β-catenin signaling pathway. PLoS One.
8:e608212013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baker SJ: PTEN enters the nuclear age.
Cell. 128:25–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
